Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

HIV-1 infection of monocytes is directly related to the success of HAART.

Almodóvar S, Del C Colón M, Maldonado IM, Villafañe R, Abreu S, Meléndez I, Domínguez C, Cuevas W, Collins TM, Lorenzo E.

Virology. 2007 Dec 5;369(1):35-46. Epub 2007 Aug 16.

2.
3.

Massively parallel pyrosequencing highlights minority variants in the HIV-1 env quasispecies deriving from lymphomonocyte sub-populations.

Rozera G, Abbate I, Bruselles A, Vlassi C, D'Offizi G, Narciso P, Chillemi G, Prosperi M, Ippolito G, Capobianchi MR.

Retrovirology. 2009 Feb 12;6:15. doi: 10.1186/1742-4690-6-15.

4.

Low-level plasma HIVs in patients on prolonged suppressive highly active antiretroviral therapy are produced mostly by cells other than CD4 T-cells.

Sahu GK, Paar D, Frost SD, Smith MM, Weaver S, Cloyd MW.

J Med Virol. 2009 Jan;81(1):9-15. doi: 10.1002/jmv.21366.

6.

Association between latent proviral characteristics and immune activation in antiretrovirus-treated human immunodeficiency virus type 1-infected adults.

Liang EC, Sceats L, Bayless NL, Strauss-Albee DM, Kubo J, Grant PM, Furman D, Desai M, Katzenstein DA, Davis MM, Zolopa AR, Blish CA.

J Virol. 2014 Aug;88(15):8629-39. doi: 10.1128/JVI.01257-14. Epub 2014 May 21.

8.

Long-term suppression of plasma viremia with highly active antiretroviral therapy despite virus evolution and very limited selection of drug-resistant genotypes.

Pariente N, Pernas M, de la Rosa R, Gómez-Mariano G, Fernández G, Rubio A, López M, Benito JM, López-Galíndez C, Leal M, Domingo E, Martinez MA, Mas A.

J Med Virol. 2004 Jul;73(3):350-61.

PMID:
15170628
9.

Macrophage HIV-1 infection in duodenal tissue of patients on long term HAART.

Zalar A, Figueroa MI, Ruibal-Ares B, Baré P, Cahn P, de Bracco MM, Belmonte L.

Antiviral Res. 2010 Aug;87(2):269-71. doi: 10.1016/j.antiviral.2010.05.005. Epub 2010 May 22.

PMID:
20471997
10.

Greater diversity of HIV DNA variants in the rectum compared to variants in the blood in patients without HAART.

Avettand-Fenoel V, Hocqueloux L, Müller-Trutwin M, Prazuck T, Melard A, Chaix ML, Agoute E, Michau C, Rouzioux C.

J Med Virol. 2011 Sep;83(9):1499-507. doi: 10.1002/jmv.22132.

PMID:
21739438
11.

Short communication: Human blood dendritic cells are infected separately from monocytes in HIV type 1 patients.

Vázquez M, Maldonado IM, Almodóvar S, López C, Colón Mdel C, Hill M, Lorenzo E.

AIDS Res Hum Retroviruses. 2010 Apr;26(4):471-9. doi: 10.1089/aid.2009.0109.

12.

Antiretroviral genotypic resistance in plasma RNA and whole blood DNA in HIV-1 infected patients failing HAART.

Saracino A, Gianotti N, Marangi M, Cibelli DC, Galli A, Punzi G, Monno L, Lazzarin A, Angarano G; Mutations, Salvage Study Group.

J Med Virol. 2008 Oct;80(10):1695-706. doi: 10.1002/jmv.21261.

PMID:
18712823
13.

Genetic analyses reveal structured HIV-1 populations in serially sampled T lymphocytes of patients receiving HAART.

Potter SJ, Lemey P, Dyer WB, Sullivan JS, Chew CB, Vandamme AM, Dwyer DE, Saksena NK.

Virology. 2006 Apr 25;348(1):35-46. Epub 2006 Feb 7.

14.

Comparative analysis of total and integrated HIV-1 DNA in peripheral CD4 lymphocytes and monocytes after long treatment with HAART.

Calcaterra S, Cappiello G, Di Caro A, Garbuglia AR, Benedetto A.

J Infect. 2001 Nov;43(4):239-45.

PMID:
11869061
15.

Decreased recovery of replication-competent HIV-1 from peripheral blood mononuclear cell-derived monocyte/macrophages of HIV-positive patients after 3 years on highly active antiretroviral therapy.

Belmonte L, Baré P, Picchio GR, Perez Bianco R, de Tezanos Pinto M, Corti M, Villafañe MF, de Bracco MM, Ruibal-Ares BH.

AIDS. 2002 Jun 14;16(9):1289-92.

PMID:
12045497
16.

IL-7 is a potent and proviral strain-specific inducer of latent HIV-1 cellular reservoirs of infected individuals on virally suppressive HAART.

Wang FX, Xu Y, Sullivan J, Souder E, Argyris EG, Acheampong EA, Fisher J, Sierra M, Thomson MM, Najera R, Frank I, Kulkosky J, Pomerantz RJ, Nunnari G.

J Clin Invest. 2005 Jan;115(1):128-37.

17.

Analysis of human immunodeficiency virus type 1 viremia and provirus in resting CD4+ T cells reveals a novel source of residual viremia in patients on antiretroviral therapy.

Brennan TP, Woods JO, Sedaghat AR, Siliciano JD, Siliciano RF, Wilke CO.

J Virol. 2009 Sep;83(17):8470-81. doi: 10.1128/JVI.02568-08. Epub 2009 Jun 17.

18.

HIV Maintains an Evolving and Dispersed Population in Multiple Tissues during Suppressive Combined Antiretroviral Therapy in Individuals with Cancer.

Rose R, Lamers SL, Nolan DJ, Maidji E, Faria NR, Pybus OG, Dollar JJ, Maruniak SA, McAvoy AC, Salemi M, Stoddart CA, Singer EJ, McGrath MS.

J Virol. 2016 Sep 29;90(20):8984-93. doi: 10.1128/JVI.00684-16. Print 2016 Oct 15.

19.

Peripheral blood Dendritic cells are not a major reservoir for HIV type 1 in infected individuals on virally suppressive HAART.

Otero M, Nunnari G, Leto D, Sullivan J, Wang FX, Frank I, Xu Y, Patel C, Dornadula G, Kulkosky J, Pomerantz RJ.

AIDS Res Hum Retroviruses. 2003 Dec;19(12):1097-103.

PMID:
14709246
20.

Factors associated with HIV-1 proviral DNA loads in patients with undetectable plasma RNA load.

Choi JY, Song YG, Kim YH, Kim CO, Kim MS, Chin BS, Han SH, Choi SH, Lee HS, Jeong SJ, Choi H, Kim JM.

J Korean Med Sci. 2009 Feb;24(1):152-4. doi: 10.3346/jkms.2009.24.1.152. Epub 2009 Feb 28.

Supplemental Content

Support Center